Delayed
Hong Kong S.E.
04:08:20 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
0.285
HKD
|
+1.79%
|
|
+7.55%
|
-62.99%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,824
|
1,241
|
1,256
|
1,329
|
1,108
|
741.7
|
Enterprise Value (EV)
1 |
1,672
|
1,237
|
976.4
|
1,244
|
1,097
|
770
|
P/E ratio
|
-26.8
x
|
-12.4
x
|
41.7
x
|
68.7
x
|
4.29
x
|
-7.77
x
|
Yield
|
-
|
-
|
-
|
-
|
0.87%
|
-
|
Capitalization / Revenue
|
25.9
x
|
21
x
|
1.92
x
|
2.13
x
|
0.6
x
|
3.5
x
|
EV / Revenue
|
23.8
x
|
20.9
x
|
1.49
x
|
1.99
x
|
0.59
x
|
3.63
x
|
EV / EBITDA
|
-28.4
x
|
-18.1
x
|
4.34
x
|
5.08
x
|
1.22
x
|
-10.7
x
|
EV / FCF
|
194
x
|
-524
x
|
3.88
x
|
49.2
x
|
5.83
x
|
14.3
x
|
FCF Yield
|
0.52%
|
-0.19%
|
25.7%
|
2.03%
|
17.1%
|
7%
|
Price to Book
|
5.63
x
|
4.29
x
|
3.66
x
|
3.36
x
|
1.84
x
|
1.6
x
|
Nbr of stocks (in thousands)
|
935,347
|
969,806
|
966,046
|
963,231
|
963,231
|
963,231
|
Reference price
2 |
1.950
|
1.280
|
1.300
|
1.380
|
1.150
|
0.7700
|
Announcement Date
|
3/28/19
|
3/30/20
|
3/29/21
|
3/31/22
|
3/29/23
|
4/1/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
70.3
|
59.21
|
655.8
|
623.8
|
1,852
|
212
|
EBITDA
1 |
-58.9
|
-68.34
|
224.9
|
245
|
900.8
|
-72.16
|
EBIT
1 |
-67.14
|
-81.73
|
195.3
|
189.5
|
845.1
|
-116.9
|
Operating Margin
|
-95.51%
|
-138.03%
|
29.79%
|
30.39%
|
45.64%
|
-55.13%
|
Earnings before Tax (EBT)
1 |
-69.24
|
-109.6
|
202.8
|
180.7
|
862.8
|
-142
|
Net income
1 |
-64.25
|
-98.84
|
30.17
|
19.38
|
258.1
|
-95.45
|
Net margin
|
-91.39%
|
-166.93%
|
4.6%
|
3.11%
|
13.94%
|
-45.03%
|
EPS
2 |
-0.0729
|
-0.1029
|
0.0312
|
0.0201
|
0.2679
|
-0.0991
|
Free Cash Flow
1 |
8.624
|
-2.36
|
251.4
|
25.28
|
188
|
53.89
|
FCF margin
|
12.27%
|
-3.99%
|
38.33%
|
4.05%
|
10.15%
|
25.42%
|
FCF Conversion (EBITDA)
|
-
|
-
|
111.79%
|
10.32%
|
20.87%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
833.26%
|
130.43%
|
72.83%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
0.0100
|
-
|
Announcement Date
|
3/28/19
|
3/30/20
|
3/29/21
|
3/31/22
|
3/29/23
|
4/1/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
28.3
|
Net Cash position
1 |
152
|
4.63
|
279
|
85.1
|
11
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-0.3923
x
|
Free Cash Flow
1 |
8.62
|
-2.36
|
251
|
25.3
|
188
|
53.9
|
ROE (net income / shareholders' equity)
|
-24.4%
|
-34%
|
40.6%
|
27.1%
|
109%
|
-21.4%
|
ROA (Net income/ Total Assets)
|
-13.1%
|
-13.5%
|
18.5%
|
14.7%
|
48.5%
|
-6.85%
|
Assets
1 |
490.8
|
729.8
|
163.2
|
131.8
|
531.9
|
1,394
|
Book Value Per Share
2 |
0.3500
|
0.3000
|
0.3600
|
0.4100
|
0.6300
|
0.4800
|
Cash Flow per Share
2 |
0.1700
|
0.0500
|
0.4000
|
0.1600
|
0.1000
|
0.0700
|
Capex
1 |
6.5
|
7.35
|
127
|
12.2
|
108
|
62.9
|
Capex / Sales
|
9.24%
|
12.41%
|
19.3%
|
1.96%
|
5.84%
|
29.66%
|
Announcement Date
|
3/28/19
|
3/30/20
|
3/29/21
|
3/31/22
|
3/29/23
|
4/1/24
|
|
1st Jan change
|
Capi.
|
---|
| -62.99% | 35.07M | | -14.92% | 84.68B | | +13.30% | 81.12B | | +11.62% | 29.4B | | -12.71% | 16.73B | | -3.06% | 16.36B | | -2.63% | 14.92B | | -31.75% | 11.77B | | -1.42% | 11.72B | | +27.44% | 11.71B |
Other Healthcare Facilities & Services
|